Identification of up-regulated Ras-like GTPase, Rap1b, by suppression subtractive hybridization

Area of Science:

• Molecular Biology
• Genetics
• Nephrology

Background:

• Diabetic nephropathy is a major cause of end-stage renal disease (ESRD), accounting for over 30% of cases.
• While several pathogenic mechanisms are known, others contributing to diabetic nephropathy remain unidentified.

Purpose of the Study:

• To identify novel genes involved in diabetic nephropathy pathogenesis during embryonic development.
• To investigate the role of the Ras-like guanine 5'-triphosphate (GTPase), Rap1b gene in diabetic kidney disease.

Main Methods:

• Suppression subtraction hybridization (SSH)-polymerase chain reaction (PCR) was used to screen for differentially expressed genes in diabetic mouse kidneys.
• Full-length Rap1b cDNA was isolated, and recombinant protein and specific antibodies were generated.
• Gene expression was analyzed using Northern blot, Western blot, in situ hybridization, and immunofluorescence.

Main Results:

• A novel cDNA fragment homologous to the human Rap1b gene was identified.
• Rap1b gene expression was significantly upregulated in the kidneys of newborn diabetic mice, with increased levels correlating with blood glucose.
• Rap1b expression was localized to collecting tubules and expanded under hyperglycemic conditions, and also observed in embryonic kidneys exposed to high glucose.

Conclusions:

• The GTP-binding protein Rap1b is upregulated in diabetic nephropathy.
• Rap1b may play a significant role in the pathobiology of diabetic kidney disease.
• Further research into Rap1b's function could reveal new therapeutic targets for diabetic nephropathy.